Personalized medicine: A perk of privilege?

14Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Advances in molecular testing and genomic technology offer promise in helping identify people at risk of developing disease and those most (or least) likely to benefit from risk reduction and treatment strategies. Yet not all of those who are eligible for such technologies have access to the benefits of these advances. Given the inequities in our health-care system, there is no assurance that expanding research into molecular and genomic testing will benefit everyone equally. Moreover, widespread adoption of new and emerging technologies poses challenges for an already overtaxed health-care system. © 2009 ASCPT.

Cite

CITATION STYLE

APA

Griggs, J. J. (2009, July). Personalized medicine: A perk of privilege? Clinical Pharmacology and Therapeutics. https://doi.org/10.1038/clpt.2009.75

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free